Navigating the Early Cancer Detection Tools of Today and Tomorrow

Cost: Complimentary


Date: On-Demand


Time: On-Demand


Produced and Sponsored by:



Cancer has become the leading cost driver in employer health plans, imposing a significant financial and human burden. These costs increase when cancer goes undetected, with one study finding the cost of treating cancer at Stage IV is nearly 4x as expensive as treating cancer at Stage I. As employers seek ways to reduce the rising costs and enhance the well-being of their employees, early detection of cancer continues to lead as the most promising and effective strategy.

The landscape of early cancer detection is changing rapidly – over the past few years, new methods of early detection have emerged, screening guidelines have been updated, and novel at-home screening modalities have become more accessible. Now more than ever, employers need to be aware of all of the tools at their disposal in order to design benefits that can reduce cancer risk among their workforce.

Join this complimentary webcast to discover tools available to your clients or your workforce to help reduce costs for employers and improve the likelihood of detecting cancer earlier. You'll learn how to:

  • Lower cancer costs and reduce the gaps in cancer prevention care
  • Increase education about and access to routine screening & prevention services
  • Discuss recent innovations that make screenings more convenient and accessible
  • Build a comprehensive cancer prevention strategy for you and your clients


Featured Speakers:

Alicia Zhou, PhD | Chief Scientific Officer | Color Health

Dr. Alicia Zhou is Color's chief science officer and leads Color's scientific affairs, medical affairs and medical operations teams. She received her Ph.D. from Harvard with a specific focus on cancer biology where her research spanned work at both the Dana-Farber Cancer Institute and the Broad Institute of M.I.T. and Harvard. She subsequently performed her postdoctoral work at UCSF. Dr. Zhou is a co-PI for the NIH's All of Us Research Program Genetic Counseling Resource. At Color, she is responsible for driving Color's scientific and research strategy, as well as managing the operations for Color's medical group, and clinical services teams.

Arif Kamal, MD, MBA, MHS, FACP, FAAHPM, FASCO | Chief Patient Officer | American Cancer Society

Dr. Arif Kamal serves as chief patient officer at the American Cancer Society. In this role, Dr. Kamal drives coordinated efforts to accelerate progress against cancer through the organization's patient-, caregiver-, and healthcare professional-facing activities. He leads the American Cancer Society's patient support objectives and the development of strategic plans to measurably improve the lives of people with cancer and their families. Dr. Kamal oversees the organization's cancer support, patient navigation, educational programs, patient lodging solutions, Transportation services, contact center, and digital patient support offerings, as well as all aspects of organizational functions that touch cancer patients across 5,000 communities around the globe. Prior to joining the American Cancer Society, Dr. Kamal served for more than 12 years as an oncologist, researcher, and innovative leader at Duke University and the Duke Cancer Institute. He is an Associate Professor of Medicine and Population Health at the Duke University School of Medicine, and recently served as physician quality and outcomes officer at the Duke Cancer Institute.


Register Now

Can't attend? Register here for an on-demand recording after the webcast.


Having issues seeing the form? Click here!

Questions? Please email [email protected] or call at (212) 457-4981